Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France

The 4CMenB, a protein-based vaccine, was licensed in Europe in 2013 against invasive meningococcal disease caused by serogroup B and is currently implemented in several countries although according to different national strategies. Isolate coverage estimation is required as vaccine-targeted antigens...

Full description

Bibliographic Details

Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Eva Hong, Aude Terrade, Alessandro Muzzi, Rosita De Paola, Giuseppe Boccadifuoco, Rita La Gaetana, Ala-Eddine Deghmane, Mariagrazia Pizza, Laura Serino, Muhamed-Kheir Taha
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-12-01
Subjects:	neisseria meningitidis 4cmenb vaccine coverage typing whole genome sequencing mats gmats mendevar
Online Access:	http://dx.doi.org/10.1080/21645515.2021.2004055